Brokers and banks usually stop taking bids earlier. Check the exact time with yours.
Total Issue Size
Fresh Issue + Offer For Sale
Fresh Issue (FI)
Proceeds go to the company
Offer For Sale (OFS)
Proceeds go to the existing investors
Repayment of Borrowings
Prepayment or repayment of outstanding borrowings availed by the company to reduce interest burdens and strengthen balance sheet leverage.
General Corporate Purposes
Funding routine operational requirements and strategic growth initiatives.
(₹ in Crore)
Tap a bar to highlight a metric across periods and show its values.
Founded in Nagpur, Maharashtra, Goldline Pharmaceutical Limited operates as a pharmaceutical marketing enterprise in India. The company adopts an asset-light corporate structure, delegating formulation and manufacturing activities to contract partners while maintaining exclusive focus on product portfolio strategy, branding, market outreach, and distribution logistics. The company markets its formulations under its proprietary Goldline brand, organizing its product portfolio into five specialized operating divisions: Goldline Pharma, Goldline Cardinal, Goldline Aayushman, Goldline InLife, and Goldline Wellness. Its commercial lines address a diverse range of therapeutic segments including cardiology, neurology, pediatrics, orthopedics, and diabetes management. Supported by a network of distributors, wholesalers, and retail pharmacies across multiple Indian states, Goldline Pharmaceutical leverages its contract manufacturing partnerships with third-party producers to scale operations without taking on heavy capital expenditures associated with physical manufacturing infrastructure.
No anchor investors added yet.
Source: RHP • Analysis provided for informational purposes
Last Updated: 24 August 2026, 5:30 PM
Asset-Light Model
The company relies on contract manufacturers for formulation production, enabling operational scalability with minimal capital expenditure on manufacturing facilities.
Broad Product Portfolio
Operates across five specialized divisions covering diverse therapeutic categories such as cardiology, neurology, pediatrics, and diabetes care.
Established Distribution Network
Maintains marketing reach across multiple regions in India through long-standing relationships with distributors, wholesalers, and retail chemist networks.
Third-Party Supplier Reliance
Total dependence on outsourced manufacturing partners exposes operations to potential supply chain disruptions, quality issues, or contract termination.
Regulatory Oversight
Pharmaceutical marketing and drug formulations are subject to stringent government quality controls and changing price control regulations.
Receivables and Working Capital Management
Operating in the pharmaceutical trade requires active management of distributor credit periods and inventory turnovers to maintain cash flows.
Goldline Pharmaceutical Limited
103, F-1, Leela Apartment, Shilpa HSG Society, Near Saptagiri Nagar, Shanidham, Narendra Nagar, Nagpur - 440015, Maharashtra, India
View on Maps →No financial information whatsoever published anywhere, within this website, should be considered as an advice to buy or sell securities or invest in IPOs, or as a guide to doing so in any way whatsoever. All matter published here is purely for educational and information purposes only and under no circumstances should be used for making investment decisions.
We are not a SEBI Registered analyst. Readers must consult a qualified financial advisor prior to making any actual investment decisions, based on information published on this website. The information on this website is based on information available as on date coupled with market perceptions.
You agree with the terms and conditions to use this website.
Grey-market disclaimer. GMP shown here is grey-market news only. We do not trade or deal in the grey market or subject-to rates, nor do we recommend trading in the grey market.
Not investment advice. IPO Nex is an information tool, not investment advice. We do not recommend buying or selling any securities. Always do your own research before applying to any IPO.
IPO Nex does not guarantee any listing gain or return. IPO investments are subject to market risks.
All times are IST.
© 2026 IPO Nex by Niota. All rights reserved.